![Safi R. Bahcall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Safi R. Bahcall
Anciens postes connus de Safi R. Bahcall
Sociétés | Poste | Début | Fin |
---|---|---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 05/10/2010 | 03/03/2014 |
Directeur Général | 01/07/2001 | 03/03/2014 | |
Fondateur | 24/07/2009 | 03/03/2014 | |
President | 01/07/2001 | 03/03/2014 |
Formation de Safi R. Bahcall
Harvard University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Safi R. Bahcall
- Expérience